0.9435
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $17.33 - Defense World
Tenaya Therapeutics appoints new interim principal accounting officer By Investing.com - Investing.com Canada
Tenaya Therapeutics Appoints Interim Accounting Officer - TipRanks
Tenaya Therapeutics Inc (TNYA) Stock: A Year of Market Fluctuations - The InvestChronicle
BlackRock, Inc. Acquires Additional Shares in Tenaya Therapeutics Inc - GuruFocus.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Tenaya Therapeutics Inc (TNYA) - SETE News
Tenaya Therapeutics (NASDAQ:TNYA) Earns "Buy" Rating from HC Wainwright - MarketBeat
Recent Insider Activity Suggests Potential Gains for Tenaya Therapeutics Inc (TNYA) - Knox Daily
Tenaya Therapeutics (NASDAQ:TNYA) Earns “Buy” Rating from HC Wainwright - Defense World
Analyze Tenaya Therapeutics Inc (NASDAQ: TNYA) Before Investing. - Stocks Register
Market Watch Highlights: Tenaya Therapeutics Inc (TNYA) Ends on an Downturn Note at 1.05 - The Dwinnex
H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock - Investing.com
Is Tenaya Therapeutics Inc (TNYA) a good investment opportunity? - US Post News
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine - GlobeNewswire
TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Tenaya Therapeutics receives $8M clinical grant from CIRM - MSN
Promising Potential of Tenaya Therapeutics: Buy Rating Justified by Financial Backing and Clinical Progress - TipRanks
Major Funding Breakthrough: Rare Heart Disease Gene Therapy Trial Gets $8M Boost - StockTitan
Tenaya Therapeutics announces option repricing to retain staff By Investing.com - Investing.com Australia
Tenaya Therapeutics announces option repricing to retain staff - Investing.com
Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely - Simply Wall St
Tenaya Therapeutics (TNYA) Stock Price, News & Analysis - MarketBeat
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares Sold by Jane Street Group LLC - Defense World
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $17.33 Average PT from Brokerages - MarketBeat
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $17.33 - Defense World
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update - MarketBeat
HC Wainwright Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA) - MarketBeat
Tenaya advances gene therapies for heart conditions By Investing.com - Investing.com Canada
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones - GlobeNewswire
Tenaya advances gene therapies for heart conditions - Investing.com
Tenaya Therapeutics Advances Gene Therapy Programs with Promising TN-201 Trial Progress - StockTitan
Analysts Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $17.33 - MarketBeat
Geode Capital Management LLC Increases Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Things To Consider Before Buying Tenaya Therapeutics Inc (NASDAQ: TNYA) - Stocks Register
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy - BioWorld Online
Largest borrow rate increases among liquid names - TipRanks
State Street Corp Purchases 9,506 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease (TNYA) - Seeking Alpha
Short Interest in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Grows By 18.8% - MarketBeat
Reviewing Caribou Biosciences (NASDAQ:CRBU) & Tenaya Therapeutics (NASDAQ:TNYA) - Defense World
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):